Skip to content

Application of laser to surgical wounds for breast cancer surgery

Photobiomodulation in operative wounds in breast surgery by Malignant Neoplasm

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
REBEC
Registry ID
RBR-6ktm4zx
Enrollment
Unknown
Registered
2023-11-22
Start date
2024-01-08
Completion date
Unknown
Last updated
2025-10-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Surgical Wound

Interventions

The "Triple Blind" masking process will first take place with the GaAIAs semiconductor of one of the devices (A or B) turned off, with the red light remaining on the light-emitting diode with optical
E07.632.490

Sponsors

Universidade Federal de São Paulo - UNIFESP/EPM
Lead Sponsor
Universidade Federal de São Paulo - UNIFESP/EPM
Collaborator

Eligibility

Sex/Gender
Female
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: Patients over 18 years of age; diagnosed with any malignant neoplasm of the breast and who will undergo breast surgery

Exclusion criteria

Exclusion criteria: Patients diagnosed with benign breast neoplasia; diagnosed with bilateral malignant neoplasm; diagnostic sectorectomy; musculocutaneous flap; inflammatory T4B staging due to dermal infiltration; with tattoo or hematoma in approximately 30% of the extent of the surgical wound

Design outcomes

Primary

MeasureTime frame
With the laser intervention, it is expected to identify a more significant reduction in local pain than in the control group, using the visual analogue and numeric scale from 0 to 10 to assess pain;With laser intervention, a more significant reduction in healing time is expected than in the control group, using the evaluation criteria of surgical points intact or not, edges approximated or not, edema, heat and redness at the site of the surgical wound;With laser intervention, it is expected to reduce the presence of seroma near or at the site of the surgical wound, which is more significant than in the control group, using this information recorded by the medical professional in the patient's medical record

Secondary

MeasureTime frame
No secondary outcomes are expected

Countries

Brazil

Contacts

Public ContactVânia Pinto

Universidade Federal de São Paulo - UNIFESP/EPM

vania.lopes@unifesp.br+55 (11) 5576-4430

Outcome results

None listed

Source: REBEC (via WHO ICTRP)